These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 10449291)

  • 1. A pilot study of exercise training to reduce trunk fat in adults with HIV-associated fat redistribution.
    Roubenoff R; Weiss L; McDermott A; Heflin T; Cloutier GJ; Wood M; Gorbach S
    AIDS; 1999 Jul; 13(11):1373-5. PubMed ID: 10449291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of highly active antiretroviral therapy on fat, lean, and bone mass in HIV-seropositive men and women.
    McDermott AY; Shevitz A; Knox T; Roubenoff R; Kehayias J; Gorbach S
    Am J Clin Nutr; 2001 Nov; 74(5):679-86. PubMed ID: 11684538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased abdominal visceral fat is associated with reduced bone density in HIV-infected men with lipodystrophy.
    Huang JS; Rietschel P; Hadigan CM; Rosenthal DI; Grinspoon S
    AIDS; 2001 May; 15(8):975-82. PubMed ID: 11399979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors.
    Carr A; Samaras K; Burton S; Law M; Freund J; Chisholm DJ; Cooper DA
    AIDS; 1998 May; 12(7):F51-8. PubMed ID: 9619798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of discontinuing stavudine or protease inhibitor therapy on human immunodeficiency virus-related fat redistribution evaluated by dual-energy x-ray absorptiometry.
    Tavassoli N; Bagheri H; Sommet A; Delpierre C; Marion-Latard F; Massip P; Aquilina C; Bonnet E; Obadia M; Labau E; Montastruc JL; Bernard J
    Pharmacotherapy; 2006 Feb; 26(2):154-61. PubMed ID: 16466321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fat distribution is altered in HIV-infected men without clinical evidence of the HIV lipodystrophy syndrome.
    Kosmiski L; Kuritzkes D; Hamilton J; Sharp T; Lichtenstien K; Hill J; Eckel R
    HIV Med; 2003 Jul; 4(3):235-40. PubMed ID: 12859322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fat distribution and metabolic changes are strongly correlated and energy expenditure is increased in the HIV lipodystrophy syndrome.
    Kosmiski LA; Kuritzkes DR; Lichtenstein KA; Glueck DH; Gourley PJ; Stamm ER; Scherzinger AL; Eckel RH
    AIDS; 2001 Oct; 15(15):1993-2000. PubMed ID: 11600828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Highly active antiretroviral-treated HIV-infected children show fat distribution changes even in absence of lipodystrophy.
    Brambilla P; Bricalli D; Sala N; Renzetti F; Manzoni P; Vanzulli A; Chiumello G; di Natale B; Viganò A
    AIDS; 2001 Dec; 15(18):2415-22. PubMed ID: 11740192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of strength and endurance training on insulin sensitivity and fat distribution in human immunodeficiency virus-infected patients with lipodystrophy.
    Lindegaard B; Hansen T; Hvid T; van Hall G; Plomgaard P; Ditlevsen S; Gerstoft J; Pedersen BK
    J Clin Endocrinol Metab; 2008 Oct; 93(10):3860-9. PubMed ID: 18628529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fasting hyperinsulinemia in human immunodeficiency virus-infected men: relationship to body composition, gonadal function, and protease inhibitor use.
    Hadigan C; Corcoran C; Stanley T; Piecuch S; Klibanski A; Grinspoon S
    J Clin Endocrinol Metab; 2000 Jan; 85(1):35-41. PubMed ID: 10634360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Switching to darunavir/ritonavir monotherapy vs. triple-therapy on body fat redistribution and bone mass in HIV-infected adults: the Monarch randomized controlled trial.
    Guaraldi G; Zona S; Cossarizza A; Vernacotola L; Carli F; Lattanzi A; Nardini G; Orlando G; Garlassi E; Termini R; Garau M
    Int J STD AIDS; 2014 Mar; 25(3):207-12. PubMed ID: 24216034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of dual-energy X-ray absorptiometry machines for measuring fat distribution changes of HIV-associated lipodystrophy.
    Yang Y; Zhu WD; Paton NI
    Antivir Ther; 2004 Oct; 9(5):771-8. PubMed ID: 15535415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV protease inhibitor substitution in patients with lipodystrophy: a randomized, controlled, open-label, multicentre study.
    Carr A; Hudson J; Chuah J; Mallal S; Law M; Hoy J; Doong N; French M; Smith D; Cooper DA;
    AIDS; 2001 Sep; 15(14):1811-22. PubMed ID: 11579243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contribution of genetic background and antiretroviral therapy to body fat changes in antiretroviral-naive HIV-infected adults.
    Egaña-Gorroño L; Martínez E; Pérez I; Escribà T; Domingo P; Gatell JM; Arnedo M
    J Antimicrob Chemother; 2014 Nov; 69(11):3076-84. PubMed ID: 25185137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Redistribution of body fat in HIV-infected women undergoing combined antiretroviral therapy.
    Gervasoni C; Ridolfo AL; Trifirò G; Santambrogio S; Norbiato G; Musicco M; Clerici M; Galli M; Moroni M
    AIDS; 1999 Mar; 13(4):465-71. PubMed ID: 10197374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of high-intensity endurance and resistance exercise on HIV metabolic abnormalities: a pilot study.
    Robinson FP; Quinn LT; Rimmer JH
    Biol Res Nurs; 2007 Jan; 8(3):177-85. PubMed ID: 17172316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of HIV infection on total body composition in treatment-naive men evaluated by dual-energy X-ray absorptiometry comparison of 90 untreated HIV-infected men to 241 controls.
    Delpierre C; Bonnet E; Marion-Latard F; Aquilina C; Obadia M; Marchou B; Massip P; Perret B; Bernard J
    J Clin Densitom; 2007; 10(4):376-80. PubMed ID: 17888698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pronounced lipoatrophy in HIV-infected men receiving HAART for more than 6 years compared with the background population.
    Hansen AB; Lindegaard B; Obel N; Andersen O; Nielsen H; Gerstoft J
    HIV Med; 2006 Jan; 7(1):38-45. PubMed ID: 16313291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of recombinant growth hormone on visceral fat accumulation: pilot study in human immunodeficiency virus-infected adolescents.
    Viganò A; Mora S; Manzoni P; Schneider L; Beretta S; Molinaro M; di Natale B; Brambilla P
    J Clin Endocrinol Metab; 2005 Jul; 90(7):4075-80. PubMed ID: 15840750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. On the trail of fugitive fat: the chase turns to NRTIs.
    Mascolini M
    J Int Assoc Physicians AIDS Care; 1999 Oct; 5(10):24-43. PubMed ID: 11366871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.